{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:47:57Z","timestamp":1755794877630,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["ETM\/266"],"award-info":[{"award-number":["ETM\/266"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2019,9,11]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Ultra-small superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect cellular inflammation within tissues and may help non-invasively identify cardiac transplant rejection. Here, we aimed to determine the normal reference values for USPIO-enhanced MRI in patients with a prior cardiac transplant and examine whether USPIO-enhanced MRI could detect myocardial inflammation in patients with transplant rejection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Ten volunteers and 11 patients with cardiac transplant underwent T2, T2* and late gadolinium enhancement 1.5T MRI, with further T2* imaging at 24\u2009hours after USPIO (ferumoxytol, 4\u2009mg\/kg) infusion, at baseline and 3 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Ten patients with clinically stable cardiac transplantation were retained for analysis. Myocardial T2 values were higher in patients with cardiac transplant versus healthy volunteers (53.8\u00b15.2 vs 48.6\u00b11.9 ms, respectively; p=0.003). There were no differences in the magnitude of USPIO-induced change in R2* in patients with transplantation (change in R2*, 26.6\u00b17.3 vs 22.0\u00b110.4\u2009s<jats:sup>-1<\/jats:sup> in healthy volunteers; p=0.28). After 3 months, patients with transplantation (n=5) had unaltered T2 values (52.7\u00b12.8 vs 52.12\u00b13.4 ms; p=0.80) and changes in R2* following USPIO (29.42\u00b18.14 vs 25.8\u00b17.8\u2009s<jats:sup>-1<\/jats:sup>; p=0.43).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Stable patients with cardiac transplantation have increased myocardial T2 values, consistent with resting myocardial oedema or fibrosis. In contrast, USPIO-enhanced MRI is normal and stable over time suggesting the absence of chronic macrophage-driven cellular inflammation. It remains to be determined whether USPIO-enhanced MRI may be able to identify acute cardiac transplant rejection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02319278349\">NCT02319278349<\/jats:ext-link> (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02319278\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02319278<\/jats:ext-link>) Registered 03.12.2014 EUDraCT 2013-002336-24.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2019-001115","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T07:15:11Z","timestamp":1570173311000},"page":"e001115","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation"],"prefix":"10.1136","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct02319278349","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02319278","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-5517","authenticated-orcid":false,"given":"Colin G","family":"Stirrat","sequence":"first","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirjel","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"MacGillivray","sequence":"additional","affiliation":[{"name":"Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calum","family":"Gray","sequence":"additional","affiliation":[{"name":"Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Richard","family":"Dweck","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Jones","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Payne","sequence":"additional","affiliation":[{"name":"Scottish National Advanced Heart Failure Service (SNAHFS), Golden Jubilee National Hospital, Clydebank, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Royal Brompton Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy S","family":"Gardner","sequence":"additional","affiliation":[{"name":"Scottish Advanced Heart Failure Unit, Golden Jubilee National Hospital, Clydebank, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK"},{"name":"Golden Jubilee National Hospital, Clydebank, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Mirsadraee","sequence":"additional","affiliation":[{"name":"Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Henriksen","sequence":"additional","affiliation":[{"name":"Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Newby","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Semple","sequence":"additional","affiliation":[{"name":"Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"2025081612095370000_6.2.e001115.1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The registry of the International Society for heart and lung transplantation: Thirty-fourth adult heart transplantation Report-2017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2025081612095370000_6.2.e001115.2","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e32834ee5b6"},{"key":"2025081612095370000_6.2.e001115.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2005.03.019"},{"key":"2025081612095370000_6.2.e001115.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.000674"},{"key":"2025081612095370000_6.2.e001115.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-311018"},{"key":"2025081612095370000_6.2.e001115.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.974907"},{"key":"2025081612095370000_6.2.e001115.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs366"},{"key":"2025081612095370000_6.2.e001115.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.110.959866"},{"key":"2025081612095370000_6.2.e001115.9","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000190","article-title":"MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA\n                  (3\n               )RS study","volume":"2","author":"McBride","year":"2015","journal-title":"Open Heart"},{"key":"2025081612095370000_6.2.e001115.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000222920.59760.df"},{"key":"2025081612095370000_6.2.e001115.11","first-page":"2039","article-title":"The atheroma (atorvastatin therapy: effects on reduction of macrophage activity) StudyEvaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease","volume":"53","author":"Tang","year":"2009","journal-title":"JAC"},{"key":"2025081612095370000_6.2.e001115.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.3.415"},{"key":"2025081612095370000_6.2.e001115.13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2251010698"},{"key":"2025081612095370000_6.2.e001115.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.rli.0000178431.38215.ae"},{"key":"2025081612095370000_6.2.e001115.15","first-page":"731","article-title":"Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance","volume":"2","author":"YL","year":"2009","journal-title":"JCMG"},{"key":"2025081612095370000_6.2.e001115.16","doi-asserted-by":"publisher","DOI":"10.1161\/hc3401.093148"},{"key":"2025081612095370000_6.2.e001115.17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/507909","article-title":"Nanoparticle enhanced MRI scanning to detect cellular inflammation in experimental chronic renal allograft rejection","volume":"2015","author":"Alam","year":"2015","journal-title":"Int J Mol Imaging"},{"key":"2025081612095370000_6.2.e001115.18","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1021\/nn3037573","article-title":"Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem","volume":"6","author":"Guo","year":"2012","journal-title":"ACS Nano"},{"key":"2025081612095370000_6.2.e001115.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.111.967836"},{"key":"2025081612095370000_6.2.e001115.20","doi-asserted-by":"crossref","unstructured":"Giri S , Chung Y-C , Merchant A , et al . T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11.doi:10.1186\/1532-429X-11-56","DOI":"10.1186\/1532-429X-11-S1-O4"},{"key":"2025081612095370000_6.2.e001115.21","doi-asserted-by":"crossref","unstructured":"Stirrat CG , Alam SR , MacGillivray TJ , et al . Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. J Cardiovasc Magn Reson 2016;18.doi:10.1186\/s12968-016-0261-2","DOI":"10.1186\/s12968-016-0261-2"},{"key":"2025081612095370000_6.2.e001115.22","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-014-0414-z"},{"key":"2025081612095370000_6.2.e001115.23","first-page":"1632","article-title":"Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation","volume":"12","author":"Dolan","year":"2019","journal-title":"JACC: Cardiovascular Imaging"},{"key":"2025081612095370000_6.2.e001115.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.111.971101"},{"key":"2025081612095370000_6.2.e001115.25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1053-2498(00)00406-X","article-title":"Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence","volume":"20","author":"Marie","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"2025081612095370000_6.2.e001115.26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/tri.12222","article-title":"Diagnostic and prognostic value of MRI T2 quantification in heart transplant patients","volume":"27","author":"Bonnemains","year":"2014","journal-title":"Transpl Int"},{"key":"2025081612095370000_6.2.e001115.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008963","article-title":"Design of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T \n                  2\n                quantification with MRI in comparison to myocardial biopsies","volume":"5","author":"Bonnemains","year":"2015","journal-title":"BMJ Open"},{"key":"2025081612095370000_6.2.e001115.28","doi-asserted-by":"crossref","unstructured":"Dabir D , Child N , Kalra A , et al . Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16.doi:10.1186\/s12968-014-0069-x","DOI":"10.1186\/s12968-014-0069-x"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2019-001115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T19:10:06Z","timestamp":1755371406000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2019-001115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,10,3]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/openhrt-2019-001115"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2019-001115","relation":{},"ISSN":["2053-3624"],"issn-type":[{"type":"electronic","value":"2053-3624"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}